A SELF-testing company has been shortlisted for a hat-trick of business and innovation awards in recognition of the cutting-edge technology behind Its at home health tests.
Test Your Intolerance uses state-of-the-art equipment to enable customers to find out what health problems, allergies and intolerances they may have.
Based in Castle Donington the company, which has been operating for 14 years, has seen a 200 per cent increase in sales of its products over the last 12 months. It is now hoping its pioneering technology, which provides scientifically validated results, will lead to award success.
The company has been announced as a finalist in the Business and Product Innovation category of the Federation of Small Businesses Celebrating Small Business Awards 2023, East Midlands.
Meanwhile, the firm’s human resources officer Lisa Hardy has been shortlisted in the Rising Star category of the British HR Awards, which set out to discover companies and individuals whose initiatives are transforming the people experience and delivering tangible value for their organisations. More than 220 entries were received from organisations across the UK.
Test Your Intolerance has also been shortlisted in the Niche Business Awards 2023, In the Best Small Business category.
Cris West, who runs Test Your Intolerance with Jason Wootton, said: “We are really grateful to have our growth and innovation recognised in this way.
“We are continually building new technologies and tests that we belleve will have huge Impacts on people’s health and, at a time when the NHS is under pressure, our innovation is more important than ever.”
The range of kits, which are approved by the Medical and Healthcare products Regulatory Authority, work by measuring reactions in the body which can uncover evidence of an allergic reaction or an intolerance.
It also supplies tests that can measure kidney and liver function, as well as a prostate health test and a kit that measures levels of vitamin D. And it has also released a menopause kit, which allows people to detect elevated levels of follicle stimulating hormone (FSH), which is a sign that they have started going through the menopause.
Mr West said: “We are continually investing into new high-tech equipment, and with new innovations in our R&D pipeline we believe 2023 will be another year of growth for us. Any awards recognition will help us boost our exports over the coming months and help people across the world with accurate, quick and cost-effective diagnostics.”
